Laboratory0112

23/09/2026

Have you ever known that the 𝗭𝗶𝗲𝗵𝗹–𝗡𝗲𝗲𝗹𝘀𝗲𝗻 (𝗭𝗡) 𝘀𝘁𝗮𝗶𝗻𝗶𝗻𝗴 technique wasn’t developed by Ziehl and Neelsen alone?

Although commonly associated with Ziehl and Neelsen, the method we use today evolved through the contributions of five scientists- 𝗥𝗼𝗯𝗲𝗿𝘁 𝗞𝗼𝗰𝗵, 𝗣𝗮𝘂𝗹 𝗘𝗵𝗿𝗹𝗶𝗰𝗵, 𝗙𝗿𝗮𝗻𝘇 𝗭𝗶𝗲𝗵𝗹, 𝗖𝗮𝗿𝗹 𝗥𝗶𝗻𝗱𝗳𝗹𝗲𝗶𝘀𝗰𝗵, 𝗮𝗻𝗱 𝗙𝗿𝗶𝗲𝗱𝗿𝗶𝗰𝗵 𝗡𝗲𝗲𝗹𝘀𝗲𝗻- each contributing an important modification to the development of acid-fast staining method we still perform today.

𝗙𝗶𝘃𝗲 𝘀𝘁𝗲𝗽𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗼𝗳 𝗭𝗡 𝘀𝘁𝗮𝗶𝗻𝗶𝗻𝗴

𝟭. 𝗥𝗼𝗯𝗲𝗿𝘁 𝗞𝗼𝗰𝗵 (𝟭𝟴𝟴𝟮)
Following his identification of the tubercle bacillus, Robert Koch demonstrated staining of tubercle bacilli using a hot alkaline methylene-blue solution, with prolonged exposure. This was among the early attempts to visualize the organism reliably in clinical material.

𝟮. 𝗣𝗮𝘂𝗹 𝗘𝗵𝗿𝗹𝗶𝗰𝗵 (𝟭𝟴𝟴𝟮)
Ehrlich recognized the remarkable resistance of tubercle bacilli to decolorization by acid—the property now termed acid-fastness. He used basic fuchsin with aniline oil as a mordant and subsequently applied dilute mineral acid for decolorization.

This observation was crucial: the bacilli could retain the primary dye while much of the surrounding material was decolorized.

𝟯. 𝗙𝗿𝗮𝗻𝘇 𝗭𝗶𝗲𝗵𝗹 (𝟭𝟴𝟴𝟮)
Ziehl replaced aniline oil with phenol (carbolic acid). This modification improved the staining system and laid the foundation for the familiar carbolfuchsin approach.

𝟰. 𝗖𝗮𝗿𝗹 𝗥𝗶𝗻𝗱𝗳𝗹𝗲𝗶𝘀𝗰𝗵 (𝟭𝟴𝟴𝟮)
Rather than immersing the specimen in a hot staining solution, Rindfleisch introduced heating directly on the stained slide. This shortened the procedure while maintaining the effect of heat on dye pe*******on.

𝟱. 𝗙𝗿𝗶𝗲𝗱𝗿𝗶𝗰𝗵 𝗡𝗲𝗲𝗹𝘀𝗲𝗻 (𝟭𝟴𝟴𝟯)
Neelsen combined basic fuchsin and carbolic acid into a single staining solution, producing the classic hot carbolfuchsin method that became associated with Ziehl and Neelsen.

Have you ever performed a ZN stain manually?

17/06/2026

Understanding Dengue Fever 🦟

18/03/2026

But tum mera dushman ho 😂😂

20/02/2026

VDRL (Venereal Disease Research Laboratory) Test
1. Objective
The objective of this test was to detect non-treponemal antibodies in serum for screening of syphilis.
________________________________________
2. Principle
The test was based on a flocculation reaction between antibodies present in the patient’s serum and cardiolipin antigen. The formation of visible clumping indicated a reactive result.
________________________________________
3. Materials
• Patient serum sample
• VDRL antigen reagent
• Glass slide
• Micropipette and tips
• Mixing stick
• Rotator
• Microscope
________________________________________
4. Procedure
• Blood was collected aseptically and serum was separated.
• A measured volume of serum was placed on a slide.
• VDRL antigen was added.
• The slide was rotated for the specified time.
• The reaction was observed microscopically.
________________________________________
5. Result
• Reactive → Visible flocculation
• Non-reactive → No flocculation
________________________________________
6. Uses
• It was used as a screening test for syphilis.
• It helped in monitoring treatment response.
• It assisted in detecting disease activity.
________________________________________
7. Consultation
Reactive results were correlated with clinical findings and confirmed by treponemal tests if necessary.

13/11/2025

11/10/2025

11/10/2025

Coombs Test (Direct and Indirect)
1. Objective:
The objective of the Coombs test was to detect antibodies that act against red blood cells (RBCs).
• The Direct Coombs Test (DCT) was used to detect antibodies or complement proteins attached directly to RBCs in the body.
• The Indirect Coombs Test (ICT) was used to detect antibodies present in the serum that could bind to RBCs.
________________________________________
2. Principle:
The test was based on antiglobulin reaction. The Coombs reagent (anti-human globulin) reacted with human antibodies or complement proteins bound to RBCs, causing agglutination (clumping).
• Direct Test: Detected antibodies already attached to patient RBCs.
• Indirect Test: Detected free antibodies present in the serum that could bind to RBCs.
________________________________________
3. Materials:
• Patient’s blood sample (EDTA tube for DCT, plain tube for ICT)
• Washed red blood cells (RBC suspension)
• Coombs (Anti-human globulin) reagent
• Centrifuge
• Test tubes
• Normal saline
• Pipettes
• Water bath (optional for warming)
________________________________________
4. Procedure:
A. Direct Coombs Test (DCT):
1. The patient’s RBCs were washed three times with normal saline.
2. One drop of washed RBCs was placed in a clean test tube.
3. One drop of Coombs reagent was added.
4. The mixture was gently mixed and centrifuged for 1 minute.
5. The tube was observed for agglutination.
B. Indirect Coombs Test (ICT):
1. Patient’s serum was incubated with test RBCs (having known antigens) at 37°C for 30 minutes.
2. The cells were then washed three times with normal saline to remove unbound antibodies.
3. One drop of Coombs reagent was added.
4. After mixing and centrifuging, the tube was observed for agglutination.
________________________________________
5. Result:
• Positive: Agglutination seen → presence of antibodies.
• Negative: No agglutination → absence of antibodies.
Test Type Positive Result Indicates
Direct Coombs Autoimmune hemolytic anemia, hemolytic disease of newborn (HDN), drug-induced hemolysis
Indirect Coombs Alloantibodies in serum, used for blood compatibility testing and prenatal screening
________________________________________
6. Uses:
• To diagnose autoimmune hemolytic anemia.
• To detect HDN (Hemolytic Disease of the Newborn).
• To perform cross-matching before blood transfusion.
• To detect antibody sensitization in pregnancy or transfusion reactions.
________________________________________
7. Consultation:
If the Coombs test was positive, the patient was advised to consult a hematologist for further investigation and management. In pregnancy, a positive indirect Coombs test required close monitoring to prevent HDN in the baby.

27/09/2025

Coombs Test (Direct and Indirect Antiglobulin Test)
1. Objective:
The objective of the Coombs test was to detect the presence of antibodies or complement proteins bound to the surface of red blood cells (RBCs). The Direct Coombs Test (DAT) aimed to identify antibodies attached directly to the patient's RBCs, while the Indirect Coombs Test (IAT) was performed to detect free antibodies present in the patient's serum that could react with RBC antigens.

2. Principle:
The principle of the Coombs test was based on the detection of antigen–antibody reactions. In the Direct Coombs Test, RBCs coated with immunoglobulin (IgG) or complement were mixed with Coombs reagent (anti-human globulin). The reagent cross-linked the sensitized RBCs, causing visible agglutination.
In the Indirect Coombs Test, the patient's serum containing antibodies was first incubated with donor or test RBCs. If the antibodies in the serum bound to the antigens on the RBCs, the subsequent addition of Coombs reagent caused agglutination. The appearance of agglutination indicated a positive test result.

3. Materials:
• Patient's blood sample (for Direct Coombs Test)
• Patient's serum (for Indirect Coombs Test)
• Test RBCs (antigen-positive cells for IAT)
• Coombs reagent (anti-human globulin serum)
• Test tubes
• Pipettes
• Centrifuge
• Microscope
• Isotonic saline solution
• Glass slides

4. Procedure (Microscopic):
a) Direct Coombs Test (DAT):
1. A blood sample was collected from the patient, and RBCs were washed three times with isotonic saline to remove unbound antibodies.
2. The washed RBC pellet was suspended in saline to make a 2–5% RBC suspension.
3. Two drops of Coombs reagent were added to the washed RBC suspension in a test tube.
4. The tube was mixed gently and centrifuged for 1–2 minutes at 1000 rpm.
5. The sediment was examined microscopically for agglutination.
6. The presence of clumping indicated a positive Direct Coombs Test.
b) Indirect Coombs Test (IAT):
1. Two drops of the patient’s serum were mixed with one drop of test RBC suspension in a test tube.
2. The mixture was incubated at 37°C for 30 minutes to allow antibodies to bind to RBC antigens.
3. After incubation, the RBCs were washed three times with saline to remove unbound antibodies.
4. Two drops of Coombs reagent were added to the washed RBCs.
5. The tube was centrifuged for 1–2 minutes and then examined microscopically.
6. Agglutination of RBCs indicated a positive Indirect Coombs Test.

5. Result:
• Positive Result: Visible clumping or agglutination of RBCs was observed under the microscope, indicating the presence of antibodies bound to RBCs (DAT) or free antibodies in the serum (IAT).
• Negative Result: No agglutination was observed, indicating the absence of significant antibodies.

6. Uses:
• To diagnose autoimmune hemolytic anemia by detecting autoantibodies attached to the patient's RBCs.
• To screen for hemolytic disease of the newborn (HDN) caused by Rh incompatibility between mother and fetus.
• To cross-match blood during transfusion to prevent hemolytic transfusion reactions.
• To detect antibodies in patients receiving multiple transfusions.
• To monitor patients for immune-mediated drug reactions affecting RBCs.

7. Consultation:
If the test result was positive, the patient was advised to consult a hematologist or immunologist for further evaluation and management. In cases of suspected hemolytic disease of the newborn, immediate neonatal care was recommended. For blood transfusion-related incompatibilities, the blood bank physician was consulted to ensure safe transfusion practices. The patient was counseled about possible causes and preventive measures, including Rh immunoglobulin administration in Rh-negative mothers.

20/09/2025

🥹

20/09/2025

A some MCQs about laboratory